Company news
Jointown Pharmaceutical Group Co., Ltd. Class A (SSE:600998) news
Jointown Pharmaceutical Group Co., Ltd. Class A news releases on 6ix. Latest, Dec 24, 2025: Indicative Announcement Completion of the Redemption and Delisting…
Press releases — page 2
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase III) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust Registration
December 23, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2026
December 19, 2025
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase II) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust Registration
December 17, 2025
Announcement on Issuance of the Phase I Asset-backed Notes for 2025 and Related Party Transactions
November 21, 2025
Announcement on Progress in Court's Acceptance of the Reorganization and Appointment of a Administrator for Aoyuan Meigu Technology Co., Ltd., a Wholly-owned Subsidiary Participating in the Reorganization Investment
November 16, 2025
Announcement on Pledge of Shareholders' Shares
November 13, 2025
Announcement on Completion of Filing for Industrial Fund Established by Holding Grandchild Subsidiary
November 11, 2025
Announcement on Outline of the Q3 2025 Performance Briefing
November 4, 2025
Announcement on Resolutions of the 17th Meeting of the 6th Board of Directors
October 27, 2025
Announcement on Entrusted Financial Management in Q3 2025
October 14, 2025
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase I) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust Registration
October 10, 2025
Announcement on Early Release of Pledge of Shareholders' Shares
September 26, 2025
Announcement on Participating in the Establishment of Industrial Fund and Related Party Transactions
September 22, 2025
Announcement on Outline of the 2025 Semi-annual Performance Briefing
September 3, 2025
Announcement on Resolutions of the 16th Meeting of the 6th Board of Directors
August 26, 2025
Announcement on Upgrading Subject Credit Rating to AAA
August 25, 2025
Announcement on Expiration of Duration and Termination of Phase III Employee Stock Ownership Plan in 2022
July 21, 2025
Announcement on Entrusted Financial Management in Q2 2025
July 16, 2025
Announcement on the Completion of Filing for the Industry Fund Established by Wholly-Owned Subsidiary
July 4, 2025
Announcement on Obtaining Drug Registration Certificate for Dexamethasone Sodium Phosphate Injection
June 20, 2025